To the editor:We read with great interest a longitudinal study by Zhang et al.1 The authors reported that transradial approach (TRA) reduced bleeding complicati
The United States Food and Drug Administration approved the prostate-specific antigen (PSA) test in 1986 for monitoring the progression of prostate cancer;in 19